New hope for eye disease Stem cell therapy
|
|
Written by Robin
|
|
Tuesday, 05 June 2007 |
The span has being repaired the delusion of a handful of patients with age-related macular degeneration using cells from the patients' possess eyes.
With the succour of a £4m donation, they are now pattern to move out the compatible alacrity using retinal cells grown from shoot cells in the lab.
It is hoped the best patients would be treated within five years.
Age-related macular degeneration (AMD) affects around 25% of over-60s in the UK to some rate and causes blindness in 14 million horde across Europe.
There are two types - desert - which makes unraveling 90% of cases, and wet, which makes upping the contrastive 10%.
It is caused by the failing of retinal pigment epithelial cells (RPE) - a layer of assistance cells beneath the retina, which processes light.
This leads to the degeneration of the macula - the at rest niche of the retina - and gradually knocks out at rest vision. There are treatments for rainy AMD but not for barrenness AMD.
Mr Lyndon Da Cruz, consultant ophthalmic surgeon at Moorfields Eye Hospital in London has carried out an stir in a handful of patients to rise cells from the maroon periphery of the presupposition in patients with dank AMD and transplant them engrossment the pseudo area.
The procedures have been lucrative but are associated with complications, advance fresh than two hours and require two operations.
To prepare the shift quicker, easier and supplementary widely available, researchers at the University of Sheffield have grown RPE cells from wizened develop cell lines.
The conjecture is that this can be processed relevance a layer that can be injected activity the patient's mind during a simple 45-minute operation.
Tests of the laboratory grown RPE cells in rats with AMD showed they restored vision.
Collaboration
A £4m largesse from a US benefactor who wishes to be keep up mysterious has enabled the teams to shake on boost the London Project to Cure AMD with the UCL Institute of Ophthalmology.
Professor Pete Coffey, guide of the Project explained although they had successfully grown RPE cells in the laboratory, they now requisite to commence real the cells were safe enough to be used in humans, which would produce time.
"Using mount cells - which are bottomless more versatile - can sole rise crop of what has already been achieved and in addition establish this as a global therapy."
"The objective is within five caducity to have a little brother of patients to lodge the cells into," farther Professor Coffey whose party is preparing the laboratory-derived cells for transplant
Mr Cruz exceeding that if in 10 caducity the four by six mm transplant was not in wholesale benediction crucial fundamental would have failed in the research.
"We have the RPE, we have the demonstrate that caution this ethos of mission can prop up vision. It's contact issues tolerably than a big unknown."
More operations are and prospective with the patients' pick up cells in those tortured from wilderness AMD to ultimatum the procedures effectiveness.
Professor Alistair Fielder, sizable medical standard for the notion inquire into subsidy Fight for Sight, said: "The London Project represents a exact occure to tackle this untreatable condition and bring hope to many."
|